Overview Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) Status: Completed Trial end date: 2010-10-01 Target enrollment: Participant gender: Summary This trial examines the way flibanserin is metabolized in postmenopausal women with Hypoactive Sexual Desire Disorder. Phase: Phase 1 Details Lead Sponsor: Sprout Pharmaceuticals, Inc